Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06182410
What this trial is testing

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Who this might be right for
Transplant-Associated Thrombotic MicroangiopathyNeuroblastomaHigh-risk Neuroblastoma+1 more
University of California, San Francisco
Early research (Phase 1)Not Yet RecruitingNCT07672964
What this trial is testing

CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical Transplantation

Who this might be right for
Hematologic MalignancyHaplo-identical HCT
Ruijin Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00903760
What this trial is testing

Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndrome
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Ended earlyNCT05086315
What this trial is testing

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more
Sanofi 101
Large-scale testing (Phase 3)Active Not RecruitingNCT03710603
What this trial is testing

Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Stichting European Myeloma Network 709
Testing effectiveness (Phase 2)Ended earlyNCT04849910
What this trial is testing

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Vor Biopharma 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT03128879
What this trial is testing

Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT01352286
What this trial is testing

Redirected Auto T Cells for Advanced Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 25
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Early research (Phase 1)WithdrawnNCT05823480
What this trial is testing

Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center
Not applicableStudy completedNCT05793073
What this trial is testing

AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients

Who this might be right for
Neutropenia
Centre Hospitalier Universitaire de Nice 55
Testing effectiveness (Phase 2)WithdrawnNCT03100877
What this trial is testing

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

Who this might be right for
Plasma Cell Leukemia in RemissionPlasma Cell Myeloma
City of Hope Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647029
What this trial is testing

A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae

Who this might be right for
Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
Fudan University 126
Early research (Phase 1)WithdrawnNCT05456269
What this trial is testing

Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+2 more
Racura Oncology Ltd
Testing effectiveness (Phase 2)Study completedNCT02420912
What this trial is testing

Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation

Who this might be right for
Loss of Chromosome 17pRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT03214666
What this trial is testing

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

Who this might be right for
High-risk Myelodysplastic SyndromesAcute Myelogenous LeukemiaSystemic Mastocytosis+1 more
GT Biopharma, Inc. 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07732712
What this trial is testing

Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 15
Testing effectiveness (Phase 2)Study completedNCT04079296
What this trial is testing

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
Astellas Pharma Global Development, Inc. 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT02960555
What this trial is testing

Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 61
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Next Page